Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom
Ladhani S.N. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. Clinical Therapeutics 2012, 34(2):385-399.
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates
Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews 2000, 13(2):302-317.
Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes
Livorsi D.J., MacNeil J.R., Cohn A.C., Bareta J., Zansky S., Petit S., et al. Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. Journal of Infection 2012, 65(6):496-504.
Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease
Ladhani S., Neely F., Heath P.T., Nazareth B., Roberts R., Slack M.P., et al. Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. Journal of Infection 2009, 58(1):3-14.
Haemophilus influenzae meningitis. A national study of secondary spread in household contacts
Ward J.I., Fraser D.W., Baraff L.J., Plikaytis B.D. Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. New England Journal of Medicine 1979, 301(3):122-126.
Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease
Murphy T.V., Clements J.F., Breedlove J.A., Hansen E.J., Seibert G.B. Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease. New England Journal of Medicine 1987, 316(1):5-10.